Representative Miller-Meeks Co-Sponsors House INSULIN Act to Cap Out-of-Pocket Costs
Representative Mariannette Miller-Meeks (R-IA) has co-sponsored the bipartisan House INSULIN Act, H.R. 10227, alongside Representatives Diana DeGette (D-CO), Kim Schrier (D-WA), Rob Bresnahan Jr. (R-PA), and Angie Craig (D-MN). This legislation aims to cap out-of-pocket insulin costs at $35 per month for individuals with private insurance. The bill also includes additional measures designed to improve insulin affordability and access. The House INSULIN Act mirrors a similar bipartisan effort in the Senate, S. 4189, which has already advanced through the Senate Health, Education, Labor and Pensions (HELP) Committee with a 17–5 vote and has been placed on the Senate Legislative Calendar. Both bills seek to address the high cost of insulin, which is a critical medication for individuals with type one diabetes (T1D). The House bill has been referred to the House Committees on Energy and Commerce, Ways and Means, and Education and Workforce.